Cannara Secures Exclusive Canadian Rights to Blue River’s Live Rosin Tech
Event summary
- Cannara Biotech has secured exclusive Canadian rights to Blue River’s Ampersand™ live rosin infusion technology.
- The deal allows Cannara to manufacture and distribute ingestible cannabis products using the proprietary solventless extraction method.
- First products under the Nugz brand are expected to launch in 5-gram containers with 500 mg of THC, pending regulatory approvals.
- Cannara’s vertically integrated operations will support production, while Blue River provides formulation expertise.
The big picture
This deal underscores the growing demand for solventless cannabis extracts and ingestible formats in Canada. By securing exclusive rights, Cannara strengthens its premium product portfolio while Blue River gains a foothold in the regulated Canadian market. The partnership highlights the strategic importance of proprietary extraction technologies in differentiating cannabis operators.
What we're watching
- Product Differentiation
- Whether Cannara can successfully position Ampersand™ as a premium ingestible option in Canada’s competitive cannabis market.
- Regulatory Approvals
- The pace at which Canadian regulators approve the new product format and provincial distributors list it for sale.
- Market Expansion
- How Cannara leverages this partnership to explore international commercialization opportunities beyond Canada.